| Gene Ontology term | Cluster frequency | Protein frequency of use | P-value |
|---|
| extracellular matrix organization | 4 out of 30 genes, 13.3% | 11 out of 533 genes, 2.1% | 0.002054316 |
| extracellular structure organization | 4 out of 30 genes, 13.3% | 11 out of 533 genes, 2.1% | 0.002054316 |
| macromolecule catabolic process | 9 out of 30 genes, 30.0% | 63 out of 533 genes, 11.8% | 0.004849205 |
| fertilization | 2 out of 30 genes, 6.7% | 3 out of 533 genes, 0.6% | 0.008880957 |
| negative regulation of response to DNA damage stimulus | 2 out of 30 genes, 6.7% | 3 out of 533 genes, 0.6% | 0.008880957 |
| macromolecular complex subunit organization | 10 out of 30 genes, 33.3% | 82 out of 533 genes, 15.4% | 0.00937959 |
| translational elongation | 5 out of 30 genes, 16.7% | 25 out of 533 genes, 4.7% | 0.009595214 |
| organic substance catabolic process | 12 out of 30 genes, 40.0% | 111 out of 533 genes, 20.8% | 0.010858 |
| cellular macromolecule catabolic process | 8 out of 30 genes, 26.7% | 59 out of 533 genes, 11.1% | 0.01153013 |
| protein complex subunit organization | 8 out of 30 genes, 26.7% | 61 out of 533 genes, 11.4% | 0.01412845 |
| catabolic process | 12 out of 30 genes, 40.0% | 115 out of 533 genes, 21.6% | 0.01457484 |
| cellular catabolic process | 11 out of 30 genes, 36.7% | 104 out of 533 genes, 19.5% | 0.01842985 |
| nucleobase-containing compound catabolic process | 8 out of 30 genes, 26.7% | 66 out of 533 genes, 12.4% | 0.02252045 |
| aromatic compound catabolic process | 8 out of 30 genes, 26.7% | 67 out of 533 genes, 12.6% | 0.02455976 |
| cellular component organization | 15 out of 30 genes, 50.0% | 169 out of 533 genes, 31.7% | 0.02456077 |
| single-organism transport | 10 out of 30 genes, 33.3% | 94 out of 533 genes, 17.6% | 0.02468554 |
| translational termination | 4 out of 30 genes, 13.3% | 21 out of 533 genes, 3.9% | 0.02497983 |
| viral genome expression | 4 out of 30 genes, 13.3% | 21 out of 533 genes, 3.9% | 0.02497983 |
| viral transcription | 4 out of 30 genes, 13.3% | 21 out of 533 genes, 3.9% | 0.02497983 |
| protein catabolic process | 5 out of 30 genes, 16.7% | 32 out of 533 genes, 6.0% | 0.02739081 |
| actin filament organization | 2 out of 30 genes, 6.7% | 5 out of 533 genes, 0.9% | 0.02756804 |
| protein complex disassembly | 4 out of 30 genes, 13.3% | 22 out of 533 genes, 4.1% | 0.02933758 |
| cellular protein complex disassembly | 4 out of 30 genes, 13.3% | 22 out of 533 genes, 4.1% | 0.02933758 |
| cellular nitrogen compound catabolic process | 8 out of 30 genes, 26.7% | 70 out of 533 genes, 13.1% | 0.03147661 |
| heterocycle catabolic process | 8 out of 30 genes, 26.7% | 70 out of 533 genes, 13.1% | 0.03147661 |
| organic cyclic compound catabolic process | 8 out of 30 genes, 26.7% | 70 out of 533 genes, 13.1% | 0.03147661 |
| protein metabolic process | 14 out of 30 genes, 46.7% | 158 out of 533 genes, 29.6% | 0.03220962 |
| viral infectious cycle | 4 out of 30 genes, 13.3% | 23 out of 533 genes, 4.3% | 0.03412665 |
| macromolecular complex disassembly | 4 out of 30 genes, 13.3% | 23 out of 533 genes, 4.3% | 0.03412665 |
| cellular lipid metabolic process | 3 out of 30 genes, 10.0% | 14 out of 533 genes, 2.6% | 0.03847241 |
| cellular component movement | 5 out of 30 genes, 16.7% | 35 out of 533 genes, 6.6% | 0.03910435 |
| cotranslational protein targeting to membrane | 4 out of 30 genes, 13.3% | 24 out of 533 genes, 4.5% | 0.03935331 |
| SRP-dependent cotranslational protein targeting to membrane | 4 out of 30 genes, 13.3% | 24 out of 533 genes, 4.5% | 0.03935331 |
| protein targeting to ER | 4 out of 30 genes, 13.3% | 24 out of 533 genes, 4.5% | 0.03935331 |
| protein localization to endoplasmic reticulum | 4 out of 30 genes, 13.3% | 24 out of 533 genes, 4.5% | 0.03935331 |
| establishment of protein localization to endoplasmic reticulum | 4 out of 30 genes, 13.3% | 24 out of 533 genes, 4.5% | 0.03935331 |
| ATP catabolic process | 2 out of 30 genes, 6.7% | 6 out of 533 genes, 1.1% | 0.03991243 |
| muscle organ development | 2 out of 30 genes, 6.7% | 6 out of 533 genes, 1.1% | 0.03991243 |
| regulation of cell cycle arrest | 2 out of 30 genes, 6.7% | 6 out of 533 genes, 1.1% | 0.03991243 |
| regulation of response to DNA damage stimulus | 2 out of 30 genes, 6.7% | 6 out of 533 genes, 1.1% | 0.03991243 |
| single-organism process | 24 out of 30 genes, 80.0% | 341 out of 533 genes, 64.0% | 0.04194272 |
| cellular component organization or biogenesis | 15 out of 30 genes, 50.0% | 180 out of 533 genes, 33.8% | 0.04376188 |
| nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 4 out of 30 genes, 13.3% | 25 out of 533 genes, 4.7% | 0.04502152 |
| protein targeting to membrane | 4 out of 30 genes, 13.3% | 26 out of 533 genes, 4.9% | 0.05113301 |
| reproductive process | 6 out of 30 genes, 20.0% | 50 out of 533 genes, 9.4% | 0.05154282 |
| translation | 6 out of 30 genes, 20.0% | 51 out of 533 genes, 9.6% | 0.05607901 |
| nuclear-transcribed mRNA catabolic process | 4 out of 30 genes, 13.3% | 27 out of 533 genes, 5.1% | 0.05768735 |
| ubiquitin-dependent protein catabolic process | 4 out of 30 genes, 13.3% | 27 out of 533 genes, 5.1% | 0.05768735 |
| modification-dependent protein catabolic process | 4 out of 30 genes, 13.3% | 27 out of 533 genes, 5.1% | 0.05768735 |
| modification-dependent macromolecule catabolic process | 4 out of 30 genes, 13.3% | 27 out of 533 genes, 5.1% | 0.05768735 |
| establishment of protein localization to organelle | 4 out of 30 genes, 13.3% | 27 out of 533 genes, 5.1% | 0.05768735 |
| RNA catabolic process | 4 out of 30 genes, 13.3% | 28 out of 533 genes, 5.3% | 0.0646821 |
| mRNA catabolic process | 4 out of 30 genes, 13.3% | 28 out of 533 genes, 5.3% | 0.0646821 |
| translational initiation | 4 out of 30 genes, 13.3% | 28 out of 533 genes, 5.3% | 0.0646821 |
| cellular component disassembly | 4 out of 30 genes, 13.3% | 28 out of 533 genes, 5.3% | 0.0646821 |
| fatty acid metabolic process | 2 out of 30 genes, 6.7% | 8 out of 533 genes, 1.5% | 0.06943152 |
| negative regulation of cell cycle process | 2 out of 30 genes, 6.7% | 8 out of 533 genes, 1.5% | 0.06943152 |
| multi-organism process | 6 out of 30 genes, 20.0% | 54 out of 533 genes, 10.1% | 0.07115063 |
| proteolysis involved in cellular protein catabolic process | 4 out of 30 genes, 13.3% | 29 out of 533 genes, 5.4% | 0.07211289 |
| protein folding | 3 out of 30 genes, 10.0% | 18 out of 533 genes, 3.4% | 0.07400495 |
| cellular protein metabolic process | 12 out of 30 genes, 40.0% | 143 out of 533 genes, 26.8% | 0.07510523 |
| reproduction | 6 out of 30 genes, 20.0% | 55 out of 533 genes, 10.3% | 0.07666672 |
| proteolysis | 5 out of 30 genes, 16.7% | 42 out of 533 genes, 7.9% | 0.07719042 |
| viral reproduction | 5 out of 30 genes, 16.7% | 42 out of 533 genes, 7.9% | 0.07719042 |
| multi-organism cellular process | 5 out of 30 genes, 16.7% | 42 out of 533 genes, 7.9% | 0.07719042 |
| cellular protein catabolic process | 4 out of 30 genes, 13.3% | 30 out of 533 genes, 5.6% | 0.0799735 |
| ATP metabolic process | 2 out of 30 genes, 6.7% | 9 out of 533 genes, 1.7% | 0.08619331 |
| cellular process involved in reproduction | 4 out of 30 genes, 13.3% | 32 out of 533 genes, 6.0% | 0.0969511 |
| positive regulation of cell differentiation | 2 out of 30 genes, 6.7% | 10 out of 533 genes, 1.9% | 0.1040427 |
| purine nucleoside catabolic process | 4 out of 30 genes, 13.3% | 33 out of 533 genes, 6.2% | 0.1060477 |
| nucleoside triphosphate catabolic process | 4 out of 30 genes, 13.3% | 33 out of 533 genes, 6.2% | 0.1060477 |
| purine nucleoside triphosphate catabolic process | 4 out of 30 genes, 13.3% | 33 out of 533 genes, 6.2% | 0.1060477 |
| nucleoside catabolic process | 4 out of 30 genes, 13.3% | 33 out of 533 genes, 6.2% | 0.1060477 |
| ribonucleoside triphosphate catabolic process | 4 out of 30 genes, 13.3% | 33 out of 533 genes, 6.2% | 0.1060477 |
| purine ribonucleoside triphosphate catabolic process | 4 out of 30 genes, 13.3% | 33 out of 533 genes, 6.2% | 0.1060477 |
| ribonucleoside catabolic process | 4 out of 30 genes, 13.3% | 33 out of 533 genes, 6.2% | 0.1060477 |
| purine ribonucleoside catabolic process | 4 out of 30 genes, 13.3% | 33 out of 533 genes, 6.2% | 0.1060477 |
| glycosyl compound catabolic process | 4 out of 30 genes, 13.3% | 33 out of 533 genes, 6.2% | 0.1060477 |
| lipid metabolic process | 3 out of 30 genes, 10.0% | 21 out of 533 genes, 3.9% | 0.1076156 |
| purine nucleotide catabolic process | 4 out of 30 genes, 13.3% | 34 out of 533 genes, 6.4% | 0.1155336 |
| purine ribonucleotide catabolic process | 4 out of 30 genes, 13.3% | 34 out of 533 genes, 6.4% | 0.1155336 |
| nucleotide catabolic process | 4 out of 30 genes, 13.3% | 34 out of 533 genes, 6.4% | 0.1155336 |
| ribonucleotide catabolic process | 4 out of 30 genes, 13.3% | 34 out of 533 genes, 6.4% | 0.1155336 |
| organophosphate catabolic process | 4 out of 30 genes, 13.3% | 34 out of 533 genes, 6.4% | 0.1155336 |
| purine-containing compound catabolic process | 4 out of 30 genes, 13.3% | 34 out of 533 genes, 6.4% | 0.1155336 |
| nucleoside phosphate catabolic process | 4 out of 30 genes, 13.3% | 34 out of 533 genes, 6.4% | 0.1155336 |
| rRNA processing | 2 out of 30 genes, 6.7% | 11 out of 533 genes, 2.1% | 0.1228136 |
| proteasomal protein catabolic process | 2 out of 30 genes, 6.7% | 11 out of 533 genes, 2.1% | 0.1228136 |
| rRNA metabolic process | 2 out of 30 genes, 6.7% | 11 out of 533 genes, 2.1% | 0.1228136 |
| sexual reproduction | 2 out of 30 genes, 6.7% | 11 out of 533 genes, 2.1% | 0.1228136 |
| monocarboxylic acid metabolic process | 2 out of 30 genes, 6.7% | 11 out of 533 genes, 2.1% | 0.1228136 |
| proteasomal ubiquitin-dependent protein catabolic process | 2 out of 30 genes, 6.7% | 11 out of 533 genes, 2.1% | 0.1228136 |
| muscle structure development | 2 out of 30 genes, 6.7% | 11 out of 533 genes, 2.1% | 0.1228136 |
| regulation of cell death | 4 out of 30 genes, 13.3% | 35 out of 533 genes, 6.6% | 0.1253955 |
| regulation of apoptotic process | 4 out of 30 genes, 13.3% | 35 out of 533 genes, 6.6% | 0.1253955 |
| regulation of programmed cell death | 4 out of 30 genes, 13.3% | 35 out of 533 genes, 6.6% | 0.1253955 |
| carbohydrate derivative catabolic process | 4 out of 30 genes, 13.3% | 35 out of 533 genes, 6.6% | 0.1253955 |
| intracellular transport | 7 out of 30 genes, 23.3% | 78 out of 533 genes, 14.6% | 0.1324952 |
| protein localization to organelle | 4 out of 30 genes, 13.3% | 36 out of 533 genes, 6.8% | 0.1356187 |
| cytoplasmic transport | 5 out of 30 genes, 16.7% | 50 out of 533 genes, 9.4% | 0.1391821 |
| macromolecule biosynthetic process | 7 out of 30 genes, 23.3% | 79 out of 533 genes, 14.8% | 0.1395156 |
| cellular macromolecule biosynthetic process | 7 out of 30 genes, 23.3% | 79 out of 533 genes, 14.8% | 0.1395156 |
| positive regulation of cell death | 2 out of 30 genes, 6.7% | 12 out of 533 genes, 2.3% | 0.142354 |
| positive regulation of apoptotic process | 2 out of 30 genes, 6.7% | 12 out of 533 genes, 2.3% | 0.142354 |
| positive regulation of programmed cell death | 2 out of 30 genes, 6.7% | 12 out of 533 genes, 2.3% | 0.142354 |
| positive regulation of developmental process | 2 out of 30 genes, 6.7% | 12 out of 533 genes, 2.3% | 0.142354 |
| viral reproductive process | 4 out of 30 genes, 13.3% | 37 out of 533 genes, 6.9% | 0.1461879 |
| RNA biosynthetic process | 4 out of 30 genes, 13.3% | 37 out of 533 genes, 6.9% | 0.1461879 |
| regulation of developmental process | 4 out of 30 genes, 13.3% | 37 out of 533 genes, 6.9% | 0.1461879 |
| regulation of cell differentiation | 3 out of 30 genes, 10.0% | 24 out of 533 genes, 4.5% | 0.1462096 |
| multi-organism reproductive process | 4 out of 30 genes, 13.3% | 38 out of 533 genes, 7.1% | 0.1570868 |
| negative regulation of macromolecule metabolic process | 5 out of 30 genes, 16.7% | 52 out of 533 genes, 9.8% | 0.1575084 |
| negative regulation of molecular function | 3 out of 30 genes, 10.0% | 25 out of 533 genes, 4.7% | 0.1600079 |
| establishment of localization in cell | 7 out of 30 genes, 23.3% | 82 out of 533 genes, 15.4% | 0.1617167 |
| microtubule-based movement | 2 out of 30 genes, 6.7% | 13 out of 533 genes, 2.4% | 0.1625252 |
| single organism reproductive process | 2 out of 30 genes, 6.7% | 13 out of 533 genes, 2.4% | 0.1625252 |
| regulation of anatomical structure size | 2 out of 30 genes, 6.7% | 13 out of 533 genes, 2.4% | 0.1625252 |
| negative regulation of metabolic process | 5 out of 30 genes, 16.7% | 53 out of 533 genes, 9.9% | 0.1670529 |
| protein targeting | 4 out of 30 genes, 13.3% | 39 out of 533 genes, 7.3% | 0.1682983 |
| purine nucleoside triphosphate metabolic process | 4 out of 30 genes, 13.3% | 39 out of 533 genes, 7.3% | 0.1682983 |
| purine ribonucleoside triphosphate metabolic process | 4 out of 30 genes, 13.3% | 39 out of 533 genes, 7.3% | 0.1682983 |
| single-organism cellular process | 21 out of 30 genes, 70.0% | 320 out of 533 genes, 60.0% | 0.1701466 |
| organic substance transport | 7 out of 30 genes, 23.3% | 84 out of 533 genes, 15.8% | 0.1774308 |
| ribonucleoside triphosphate metabolic process | 4 out of 30 genes, 13.3% | 40 out of 533 genes, 7.5% | 0.1798048 |
| purine nucleoside metabolic process | 4 out of 30 genes, 13.3% | 40 out of 533 genes, 7.5% | 0.1798048 |
| purine ribonucleoside metabolic process | 4 out of 30 genes, 13.3% | 40 out of 533 genes, 7.5% | 0.1798048 |
| organonitrogen compound catabolic process | 4 out of 30 genes, 13.3% | 40 out of 533 genes, 7.5% | 0.1798048 |
| localization | 11 out of 30 genes, 36.7% | 148 out of 533 genes, 27.8% | 0.1798949 |
| transport | 10 out of 30 genes, 33.3% | 132 out of 533 genes, 24.8% | 0.1818679 |
| regulation of cell cycle process | 2 out of 30 genes, 6.7% | 14 out of 533 genes, 2.6% | 0.1832006 |
| negative regulation of developmental process | 2 out of 30 genes, 6.7% | 14 out of 533 genes, 2.6% | 0.1832006 |
| establishment of localization | 10 out of 30 genes, 33.3% | 133 out of 533 genes, 25.0% | 0.1886708 |
| nucleoside triphosphate metabolic process | 4 out of 30 genes, 13.3% | 41 out of 533 genes, 7.7% | 0.1915883 |
| ribonucleoside metabolic process | 4 out of 30 genes, 13.3% | 42 out of 533 genes, 7.9% | 0.2036302 |
| regulation of phosphate metabolic process | 4 out of 30 genes, 13.3% | 42 out of 533 genes, 7.9% | 0.2036302 |
| regulation of phosphorus metabolic process | 4 out of 30 genes, 13.3% | 42 out of 533 genes, 7.9% | 0.2036302 |
| regulation of phosphorylation | 3 out of 30 genes, 10.0% | 28 out of 533 genes, 5.3% | 0.2036653 |
| negative regulation of response to stimulus | 3 out of 30 genes, 10.0% | 28 out of 533 genes, 5.3% | 0.2036653 |
| actin cytoskeleton organization | 2 out of 30 genes, 6.7% | 15 out of 533 genes, 2.8% | 0.2042652 |
| negative regulation of protein modification process | 2 out of 30 genes, 6.7% | 15 out of 533 genes, 2.8% | 0.2042652 |
| ncRNA processing | 2 out of 30 genes, 6.7% | 15 out of 533 genes, 2.8% | 0.2042652 |
| regulation of cellular response to stress | 2 out of 30 genes, 6.7% | 15 out of 533 genes, 2.8% | 0.2042652 |
| protein transport | 6 out of 30 genes, 20.0% | 72 out of 533 genes, 13.5% | 0.2063263 |
| establishment of protein localization | 6 out of 30 genes, 20.0% | 73 out of 533 genes, 13.7% | 0.2158155 |
| purine nucleotide metabolic process | 4 out of 30 genes, 13.3% | 43 out of 533 genes, 8.1% | 0.2159117 |
| nucleoside metabolic process | 4 out of 30 genes, 13.3% | 43 out of 533 genes, 8.1% | 0.2159117 |
| purine ribonucleotide metabolic process | 4 out of 30 genes, 13.3% | 43 out of 533 genes, 8.1% | 0.2159117 |
| purine-containing compound metabolic process | 4 out of 30 genes, 13.3% | 43 out of 533 genes, 8.1% | 0.2159117 |
| glycosyl compound metabolic process | 4 out of 30 genes, 13.3% | 43 out of 533 genes, 8.1% | 0.2159117 |
| cell motility | 2 out of 30 genes, 6.7% | 16 out of 533 genes, 3.0% | 0.2256145 |
| localization of cell | 2 out of 30 genes, 6.7% | 16 out of 533 genes, 3.0% | 0.2256145 |
| ribonucleotide metabolic process | 4 out of 30 genes, 13.3% | 44 out of 533 genes, 8.3% | 0.2284137 |
| ribose phosphate metabolic process | 4 out of 30 genes, 13.3% | 44 out of 533 genes, 8.3% | 0.2284137 |
| cell adhesion | 3 out of 30 genes, 10.0% | 30 out of 533 genes, 5.6% | 0.2342745 |
| biological adhesion | 3 out of 30 genes, 10.0% | 30 out of 533 genes, 5.6% | 0.2342745 |
| cellular macromolecular complex assembly | 3 out of 30 genes, 10.0% | 30 out of 533 genes, 5.6% | 0.2342745 |
| homeostatic process | 3 out of 30 genes, 10.0% | 30 out of 533 genes, 5.6% | 0.2342745 |
| cellular localization | 7 out of 30 genes, 23.3% | 91 out of 533 genes, 17.1% | 0.2376083 |
| apoptotic process | 2 out of 30 genes, 6.7% | 17 out of 533 genes, 3.2% | 0.2471538 |
| positive regulation of cell proliferation | 2 out of 30 genes, 6.7% | 17 out of 533 genes, 3.2% | 0.2471538 |
| tissue development | 2 out of 30 genes, 6.7% | 17 out of 533 genes, 3.2% | 0.2471538 |
| programmed cell death | 2 out of 30 genes, 6.7% | 17 out of 533 genes, 3.2% | 0.2471538 |
| chemical homeostasis | 2 out of 30 genes, 6.7% | 17 out of 533 genes, 3.2% | 0.2471538 |
| negative regulation of cellular metabolic process | 4 out of 30 genes, 13.3% | 46 out of 533 genes, 8.6% | 0.2540028 |
| macromolecule localization | 7 out of 30 genes, 23.3% | 94 out of 533 genes, 17.6% | 0.2655334 |
| cell death | 2 out of 30 genes, 6.7% | 18 out of 533 genes, 3.4% | 0.2687974 |
| death | 2 out of 30 genes, 6.7% | 18 out of 533 genes, 3.4% | 0.2687974 |
| ribosome biogenesis | 2 out of 30 genes, 6.7% | 18 out of 533 genes, 3.4% | 0.2687974 |
| macromolecule metabolic process | 15 out of 30 genes, 50.0% | 229 out of 533 genes, 43.0% | 0.2690945 |
| actin filament-based process | 2 out of 30 genes, 6.7% | 19 out of 533 genes, 3.6% | 0.2904682 |
| cellular biosynthetic process | 8 out of 30 genes, 26.7% | 114 out of 533 genes, 21.4% | 0.2997066 |
| cellular macromolecule metabolic process | 14 out of 30 genes, 46.7% | 216 out of 533 genes, 40.5% | 0.3012062 |
| macromolecular complex assembly | 4 out of 30 genes, 13.3% | 50 out of 533 genes, 9.4% | 0.3069865 |
| mRNA metabolic process | 5 out of 30 genes, 16.7% | 66 out of 533 genes, 12.4% | 0.3090648 |
| negative regulation of cellular protein metabolic process | 2 out of 30 genes, 6.7% | 20 out of 533 genes, 3.8% | 0.3120968 |
| positive regulation of phosphorylation | 2 out of 30 genes, 6.7% | 20 out of 533 genes, 3.8% | 0.3120968 |
| regulation of protein modification process | 3 out of 30 genes, 10.0% | 35 out of 533 genes, 6.6% | 0.3139576 |
| nucleoside phosphate metabolic process | 4 out of 30 genes, 13.3% | 51 out of 533 genes, 9.6% | 0.320499 |
| intracellular protein transport | 4 out of 30 genes, 13.3% | 51 out of 533 genes, 9.6% | 0.320499 |
| nucleotide metabolic process | 4 out of 30 genes, 13.3% | 51 out of 533 genes, 9.6% | 0.320499 |
| regulation of cellular protein metabolic process | 4 out of 30 genes, 13.3% | 51 out of 533 genes, 9.6% | 0.320499 |
| carbohydrate derivative metabolic process | 4 out of 30 genes, 13.3% | 51 out of 533 genes, 9.6% | 0.320499 |
| protein localization | 6 out of 30 genes, 20.0% | 84 out of 533 genes, 15.8% | 0.3293164 |
| microtubule-based process | 2 out of 30 genes, 6.7% | 21 out of 533 genes, 3.9% | 0.3336212 |
| ncRNA metabolic process | 2 out of 30 genes, 6.7% | 21 out of 533 genes, 3.9% | 0.3336212 |
| negative regulation of catalytic activity | 2 out of 30 genes, 6.7% | 21 out of 533 genes, 3.9% | 0.3336212 |
| regulation of catalytic activity | 4 out of 30 genes, 13.3% | 52 out of 533 genes, 9.8% | 0.3340816 |
| organic substance biosynthetic process | 8 out of 30 genes, 26.7% | 118 out of 533 genes, 22.1% | 0.3373509 |
| organophosphate metabolic process | 4 out of 30 genes, 13.3% | 53 out of 533 genes, 9.9% | 0.3477166 |
| positive regulation of phosphorus metabolic process | 2 out of 30 genes, 6.7% | 22 out of 533 genes, 4.1% | 0.3549858 |
| regulation of MAPK cascade | 2 out of 30 genes, 6.7% | 22 out of 533 genes, 4.1% | 0.3549858 |
| positive regulation of phosphate metabolic process | 2 out of 30 genes, 6.7% | 22 out of 533 genes, 4.1% | 0.3549858 |
| negative regulation of protein metabolic process | 2 out of 30 genes, 6.7% | 22 out of 533 genes, 4.1% | 0.3549858 |
| biosynthetic process | 8 out of 30 genes, 26.7% | 120 out of 533 genes, 22.5% | 0.3565799 |
| regulation of response to stimulus | 5 out of 30 genes, 16.7% | 71 out of 533 genes, 13.3% | 0.3691558 |
| regulation of biological quality | 5 out of 30 genes, 16.7% | 71 out of 533 genes, 13.3% | 0.3691558 |
| RNA metabolic process | 6 out of 30 genes, 20.0% | 88 out of 533 genes, 16.5% | 0.3733218 |
| nucleobase-containing compound biosynthetic process | 4 out of 30 genes, 13.3% | 55 out of 533 genes, 10.3% | 0.3750755 |
| nucleobase-containing small molecule metabolic process | 4 out of 30 genes, 13.3% | 55 out of 533 genes, 10.3% | 0.3750755 |
| cell cycle phase | 2 out of 30 genes, 6.7% | 23 out of 533 genes, 4.3% | 0.3761413 |
| protein modification by small protein conjugation or removal | 2 out of 30 genes, 6.7% | 23 out of 533 genes, 4.3% | 0.3761413 |
| cellular component biogenesis | 6 out of 30 genes, 20.0% | 89 out of 533 genes, 16.7% | 0.3844303 |
| positive regulation of cellular process | 7 out of 30 genes, 23.3% | 106 out of 533 genes, 19.9% | 0.3857196 |
| gene expression | 7 out of 30 genes, 23.3% | 107 out of 533 genes, 20.1% | 0.3961021 |
| mitotic cell cycle | 2 out of 30 genes, 6.7% | 24 out of 533 genes, 4.5% | 0.3970442 |
| negative regulation of signal transduction | 2 out of 30 genes, 6.7% | 24 out of 533 genes, 4.5% | 0.3970442 |
| cellular component assembly | 5 out of 30 genes, 16.7% | 74 out of 533 genes, 13.9% | 0.4056501 |
| anatomical structure development | 5 out of 30 genes, 16.7% | 74 out of 533 genes, 13.9% | 0.4056501 |
| regulation of signal transduction | 4 out of 30 genes, 13.3% | 58 out of 533 genes, 10.9% | 0.4160923 |
| aromatic compound biosynthetic process | 4 out of 30 genes, 13.3% | 58 out of 533 genes, 10.9% | 0.4160923 |
| regulation of protein phosphorylation | 2 out of 30 genes, 6.7% | 25 out of 533 genes, 4.7% | 0.417656 |
| ribonucleoprotein complex biogenesis | 2 out of 30 genes, 6.7% | 25 out of 533 genes, 4.7% | 0.417656 |
| regulation of cell cycle | 2 out of 30 genes, 6.7% | 25 out of 533 genes, 4.7% | 0.417656 |
| heterocycle biosynthetic process | 4 out of 30 genes, 13.3% | 59 out of 533 genes, 11.1% | 0.4296975 |
| cellular nitrogen compound biosynthetic process | 4 out of 30 genes, 13.3% | 59 out of 533 genes, 11.1% | 0.4296975 |
| regulation of immune system process | 2 out of 30 genes, 6.7% | 26 out of 533 genes, 4.9% | 0.4379433 |
| negative regulation of cell communication | 2 out of 30 genes, 6.7% | 26 out of 533 genes, 4.9% | 0.4379433 |
| negative regulation of signaling | 2 out of 30 genes, 6.7% | 26 out of 533 genes, 4.9% | 0.4379433 |
| regulation of hydrolase activity | 2 out of 30 genes, 6.7% | 26 out of 533 genes, 4.9% | 0.4379433 |
| cellular protein localization | 4 out of 30 genes, 13.3% | 60 out of 533 genes, 11.3% | 0.4432454 |
| cellular macromolecule localization | 4 out of 30 genes, 13.3% | 60 out of 533 genes, 11.3% | 0.4432454 |
| primary metabolic process | 18 out of 30 genes, 60.0% | 304 out of 533 genes, 57.0% | 0.4445036 |
| small molecule metabolic process | 6 out of 30 genes, 20.0% | 95 out of 533 genes, 17.8% | 0.4513049 |
| nucleobase-containing compound metabolic process | 10 out of 30 genes, 33.3% | 165 out of 533 genes, 31.0% | 0.4564343 |
| regulation of protein metabolic process | 4 out of 30 genes, 13.3% | 61 out of 533 genes, 11.4% | 0.4567224 |
| GTP catabolic process | 2 out of 30 genes, 6.7% | 27 out of 533 genes, 5.1% | 0.4578768 |
| regulation of response to stress | 2 out of 30 genes, 6.7% | 27 out of 533 genes, 5.1% | 0.4578768 |
| guanosine-containing compound catabolic process | 2 out of 30 genes, 6.7% | 27 out of 533 genes, 5.1% | 0.4578768 |
| single-organism metabolic process | 7 out of 30 genes, 23.3% | 113 out of 533 genes, 21.2% | 0.4586335 |
| regulation of cellular metabolic process | 9 out of 30 genes, 30.0% | 148 out of 533 genes, 27.8% | 0.4605764 |
| regulation of metabolic process | 10 out of 30 genes, 33.3% | 166 out of 533 genes, 31.1% | 0.4656059 |
| nucleic acid metabolic process | 7 out of 30 genes, 23.3% | 114 out of 533 genes, 21.4% | 0.4690306 |
| organic cyclic compound biosynthetic process | 4 out of 30 genes, 13.3% | 62 out of 533 genes, 11.6% | 0.4701157 |
| cytoskeleton organization | 2 out of 30 genes, 6.7% | 28 out of 533 genes, 5.3% | 0.4774316 |
| positive regulation of protein modification process | 2 out of 30 genes, 6.7% | 28 out of 533 genes, 5.3% | 0.4774316 |
| locomotion | 2 out of 30 genes, 6.7% | 28 out of 533 genes, 5.3% | 0.4774316 |
| organelle organization | 5 out of 30 genes, 16.7% | 80 out of 533 genes, 15.0% | 0.478217 |
| regulation of primary metabolic process | 9 out of 30 genes, 30.0% | 150 out of 533 genes, 28.1% | 0.4795244 |
| positive regulation of biological process | 7 out of 30 genes, 23.3% | 116 out of 533 genes, 21.8% | 0.489744 |
| cellular aromatic compound metabolic process | 10 out of 30 genes, 33.3% | 169 out of 533 genes, 31.7% | 0.4930863 |
| negative regulation of cellular process | 6 out of 30 genes, 20.0% | 99 out of 533 genes, 18.6% | 0.4954933 |
| organic acid metabolic process | 2 out of 30 genes, 6.7% | 29 out of 533 genes, 5.4% | 0.4965862 |
| protein complex assembly | 2 out of 30 genes, 6.7% | 29 out of 533 genes, 5.4% | 0.4965862 |
| carboxylic acid metabolic process | 2 out of 30 genes, 6.7% | 29 out of 533 genes, 5.4% | 0.4965862 |
| oxoacid metabolic process | 2 out of 30 genes, 6.7% | 29 out of 533 genes, 5.4% | 0.4965862 |
| heterocycle metabolic process | 10 out of 30 genes, 33.3% | 170 out of 533 genes, 31.9% | 0.5022197 |
| organic substance metabolic process | 18 out of 30 genes, 60.0% | 311 out of 533 genes, 58.3% | 0.5045264 |
| negative regulation of nucleobase-containing compound metabolic process | 2 out of 30 genes, 6.7% | 30 out of 533 genes, 5.6% | 0.5153227 |
| GTP metabolic process | 2 out of 30 genes, 6.7% | 30 out of 533 genes, 5.6% | 0.5153227 |
| negative regulation of nitrogen compound metabolic process | 2 out of 30 genes, 6.7% | 30 out of 533 genes, 5.6% | 0.5153227 |
| protein complex biogenesis | 2 out of 30 genes, 6.7% | 30 out of 533 genes, 5.6% | 0.5153227 |
| guanosine-containing compound metabolic process | 2 out of 30 genes, 6.7% | 30 out of 533 genes, 5.6% | 0.5153227 |
| cellular process | 26 out of 30 genes, 86.7% | 453 out of 533 genes, 85.0% | 0.521783 |
| regulation of cell communication | 4 out of 30 genes, 13.3% | 66 out of 533 genes, 12.4% | 0.5226169 |
| regulation of molecular function | 4 out of 30 genes, 13.3% | 66 out of 533 genes, 12.4% | 0.5226169 |
| biological regulation | 16 out of 30 genes, 53.3% | 279 out of 533 genes, 52.3% | 0.5314983 |
| organ development | 2 out of 30 genes, 6.7% | 31 out of 533 genes, 5.8% | 0.5336264 |
| regulation of multicellular organismal process | 3 out of 30 genes, 10.0% | 49 out of 533 genes, 9.2% | 0.5342061 |
| cellular metabolic process | 17 out of 30 genes, 56.7% | 297 out of 533 genes, 55.7% | 0.5351554 |
| regulation of signaling | 4 out of 30 genes, 13.3% | 67 out of 533 genes, 12.6% | 0.5354209 |
| cellular nitrogen compound metabolic process | 10 out of 30 genes, 33.3% | 174 out of 533 genes, 32.6% | 0.5385021 |
| positive regulation of signal transduction | 2 out of 30 genes, 6.7% | 32 out of 533 genes, 6.0% | 0.5514852 |
| regulation of intracellular protein kinase cascade | 2 out of 30 genes, 6.7% | 32 out of 533 genes, 6.0% | 0.5514852 |
| positive regulation of cell communication | 2 out of 30 genes, 6.7% | 32 out of 533 genes, 6.0% | 0.5514852 |
| positive regulation of signaling | 2 out of 30 genes, 6.7% | 32 out of 533 genes, 6.0% | 0.5514852 |
| positive regulation of cellular protein metabolic process | 2 out of 30 genes, 6.7% | 32 out of 533 genes, 6.0% | 0.5514852 |
| organic cyclic compound metabolic process | 10 out of 30 genes, 33.3% | 176 out of 533 genes, 33.0% | 0.5564327 |
| organonitrogen compound metabolic process | 4 out of 30 genes, 13.3% | 69 out of 533 genes, 12.9% | 0.5605773 |
| system development | 3 out of 30 genes, 10.0% | 51 out of 533 genes, 9.6% | 0.5629727 |
| negative regulation of gene expression | 2 out of 30 genes, 6.7% | 33 out of 533 genes, 6.2% | 0.5688899 |
| cell cycle process | 2 out of 30 genes, 6.7% | 33 out of 533 genes, 6.2% | 0.5688899 |
| regulation of cellular process | 14 out of 30 genes, 46.7% | 249 out of 533 genes, 46.7% | 0.5753189 |
| regulation of localization | 3 out of 30 genes, 10.0% | 52 out of 533 genes, 9.8% | 0.5769864 |
| negative regulation of biological process | 6 out of 30 genes, 20.0% | 107 out of 533 genes, 20.1% | 0.580799 |
| multicellular organismal development | 4 out of 30 genes, 13.3% | 71 out of 533 genes, 13.3% | 0.5850779 |
| positive regulation of catalytic activity | 2 out of 30 genes, 6.7% | 34 out of 533 genes, 6.4% | 0.5858333 |
| metabolic process | 18 out of 30 genes, 60.0% | 321 out of 533 genes, 60.2% | 0.5904137 |
| regulation of biosynthetic process | 6 out of 30 genes, 20.0% | 108 out of 533 genes, 20.3% | 0.5910514 |
| nitrogen compound metabolic process | 10 out of 30 genes, 33.3% | 181 out of 533 genes, 34.0% | 0.6003859 |
| regulation of macromolecule metabolic process | 8 out of 30 genes, 26.7% | 146 out of 533 genes, 27.4% | 0.6084365 |
| positive regulation of protein metabolic process | 2 out of 30 genes, 6.7% | 36 out of 533 genes, 6.8% | 0.6183189 |
| cell differentiation | 3 out of 30 genes, 10.0% | 56 out of 533 genes, 10.5% | 0.6303994 |
| phosphorus metabolic process | 4 out of 30 genes, 13.3% | 75 out of 533 genes, 14.1% | 0.6318965 |
| phosphate-containing compound metabolic process | 4 out of 30 genes, 13.3% | 75 out of 533 genes, 14.1% | 0.6318965 |
| positive regulation of response to stimulus | 2 out of 30 genes, 6.7% | 37 out of 533 genes, 6.9% | 0.6338569 |
| developmental process | 5 out of 30 genes, 16.7% | 94 out of 533 genes, 17.6% | 0.6356165 |
| response to stress | 4 out of 30 genes, 13.3% | 76 out of 533 genes, 14.3% | 0.6431146 |
| immune system process | 2 out of 30 genes, 6.7% | 38 out of 533 genes, 7.1% | 0.648925 |
| regulation of cell proliferation | 2 out of 30 genes, 6.7% | 39 out of 533 genes, 7.3% | 0.663525 |
| regulation of gene expression | 6 out of 30 genes, 20.0% | 116 out of 533 genes, 21.8% | 0.6687701 |
| cell cycle | 2 out of 30 genes, 6.7% | 40 out of 533 genes, 7.5% | 0.6776598 |
| regulation of cellular macromolecule biosynthetic process | 5 out of 30 genes, 16.7% | 99 out of 533 genes, 18.6% | 0.6851812 |
| cellular developmental process | 3 out of 30 genes, 10.0% | 61 out of 533 genes, 11.4% | 0.6908571 |
| regulation of transcription, DNA-dependent | 4 out of 30 genes, 13.3% | 82 out of 533 genes, 15.4% | 0.7060442 |
| regulation of biological process | 14 out of 30 genes, 46.7% | 267 out of 533 genes, 50.1% | 0.7168278 |
| positive regulation of molecular function | 2 out of 30 genes, 6.7% | 43 out of 533 genes, 8.1% | 0.7173203 |
| regulation of macromolecule biosynthetic process | 5 out of 30 genes, 16.7% | 103 out of 533 genes, 19.3% | 0.7217652 |
| regulation of RNA biosynthetic process | 4 out of 30 genes, 13.3% | 84 out of 533 genes, 15.8% | 0.7252986 |
| single-organism developmental process | 3 out of 30 genes, 10.0% | 65 out of 533 genes, 12.2% | 0.7340119 |
| regulation of cellular biosynthetic process | 5 out of 30 genes, 16.7% | 105 out of 533 genes, 19.7% | 0.7389928 |
| single-multicellular organism process | 4 out of 30 genes, 13.3% | 88 out of 533 genes, 16.5% | 0.7611799 |
| positive regulation of cellular metabolic process | 3 out of 30 genes, 10.0% | 69 out of 533 genes, 12.9% | 0.7725741 |
| positive regulation of macromolecule metabolic process | 3 out of 30 genes, 10.0% | 70 out of 533 genes, 13.1% | 0.7815141 |
| RNA processing | 2 out of 30 genes, 6.7% | 49 out of 533 genes, 9.2% | 0.7849074 |
| regulation of RNA metabolic process | 4 out of 30 genes, 13.3% | 92 out of 533 genes, 17.3% | 0.7935832 |
| intracellular signal transduction | 2 out of 30 genes, 6.7% | 50 out of 533 genes, 9.4% | 0.794749 |
| multicellular organismal process | 4 out of 30 genes, 13.3% | 93 out of 533 genes, 17.4% | 0.80115 |
| regulation of nitrogen compound metabolic process | 5 out of 30 genes, 16.7% | 115 out of 533 genes, 21.6% | 0.8143369 |
| positive regulation of metabolic process | 3 out of 30 genes, 10.0% | 75 out of 533 genes, 14.1% | 0.8221876 |
| regulation of nucleobase-containing compound metabolic process | 4 out of 30 genes, 13.3% | 111 out of 533 genes, 20.8% | 0.9042343 |
| cellular protein modification process | 2 out of 30 genes, 6.7% | 66 out of 533 genes, 12.4% | 0.9072085 |
| protein modification process | 2 out of 30 genes, 6.7% | 66 out of 533 genes, 12.4% | 0.9072085 |
| macromolecule modification | 2 out of 30 genes, 6.7% | 69 out of 533 genes, 12.9% | 0.9207232 |
| signal transduction | 3 out of 30 genes, 10.0% | 99 out of 533 genes, 18.6% | 0.9411134 |
| signaling | 3 out of 30 genes, 10.0% | 103 out of 533 genes, 19.3% | 0.9518592 |
| single organism signaling | 3 out of 30 genes, 10.0% | 103 out of 533 genes, 19.3% | 0.9518592 |
| cell communication | 3 out of 30 genes, 10.0% | 107 out of 533 genes, 20.1% | 0.960827 |
| response to stimulus | 6 out of 30 genes, 20.0% | 175 out of 533 genes, 32.8% | 0.9640348 |
| cellular response to stimulus | 4 out of 30 genes, 13.3% | 133 out of 533 genes, 25.0% | 0.9659531 |
| Gene Ontology term | Genes annotated to the term |
|---|
| extracellular matrix organization | ENSAPLP00000013972, ENSAPLP00000009873, ENSAPLP00000003689, ENSAPLP00000006049 |
| extracellular structure organization | ENSAPLP00000013972, ENSAPLP00000009873, ENSAPLP00000003689, ENSAPLP00000006049 |
| macromolecule catabolic process | ENSAPLP00000008397, ENSAPLP00000006744, ENSAPLP00000014548, ENSAPLP00000015706, ENSAPLP00000009200, ENSAPLP00000011529, ENSAPLP00000015238, ENSAPLP00000014372, ENSAPLP00000011722 |
| fertilization | ENSAPLP00000011900, ENSAPLP00000011529 |
| negative regulation of response to DNA damage stimulus | ENSAPLP00000005038, ENSAPLP00000014372 |
| macromolecular complex subunit organization | ENSAPLP00000008397, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000015503, ENSAPLP00000015617, ENSAPLP00000009200, ENSAPLP00000015238, ENSAPLP00000014372, ENSAPLP00000002381 |
| translational elongation | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000009114, ENSAPLP00000014372 |
| organic substance catabolic process | ENSAPLP00000008397, ENSAPLP00000006744, ENSAPLP00000014548, ENSAPLP00000015503, ENSAPLP00000015706, ENSAPLP00000009200, ENSAPLP00000011529, ENSAPLP00000009741, ENSAPLP00000009114, ENSAPLP00000015238, ENSAPLP00000014372, ENSAPLP00000011722 |
| cellular macromolecule catabolic process | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000006744, ENSAPLP00000014548, ENSAPLP00000014372, ENSAPLP00000011722, ENSAPLP00000015706 |
| protein complex subunit organization | ENSAPLP00000008397, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000015503, ENSAPLP00000009200, ENSAPLP00000015238, ENSAPLP00000014372, ENSAPLP00000002381 |
| catabolic process | ENSAPLP00000008397, ENSAPLP00000006744, ENSAPLP00000014548, ENSAPLP00000015503, ENSAPLP00000015706, ENSAPLP00000009200, ENSAPLP00000011529, ENSAPLP00000009741, ENSAPLP00000009114, ENSAPLP00000015238, ENSAPLP00000014372, ENSAPLP00000011722 |
| cellular catabolic process | ENSAPLP00000008397, ENSAPLP00000006744, ENSAPLP00000014548, ENSAPLP00000015503, ENSAPLP00000015706, ENSAPLP00000009200, ENSAPLP00000011529, ENSAPLP00000009114, ENSAPLP00000015238, ENSAPLP00000014372, ENSAPLP00000011722 |
| nucleobase-containing compound catabolic process | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000009114, ENSAPLP00000014372, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| aromatic compound catabolic process | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000009114, ENSAPLP00000014372, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| cellular component organization | ENSAPLP00000009873, ENSAPLP00000008397, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000002296, ENSAPLP00000003689, ENSAPLP00000014548, ENSAPLP00000015503, ENSAPLP00000013972, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000015238, ENSAPLP00000006049, ENSAPLP00000014372, ENSAPLP00000002381 |
| single-organism transport | ENSAPLP00000008397, ENSAPLP00000011711, ENSAPLP00000006744, ENSAPLP00000008444, ENSAPLP00000015679, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000015238, ENSAPLP00000014372 |
| translational termination | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| viral genome expression | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| viral transcription | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| protein catabolic process | ENSAPLP00000011529, ENSAPLP00000006744, ENSAPLP00000014548, ENSAPLP00000011722, ENSAPLP00000015706 |
| actin filament organization | ENSAPLP00000014548, ENSAPLP00000002381 |
| protein complex disassembly | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| cellular protein complex disassembly | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| cellular nitrogen compound catabolic process | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000009114, ENSAPLP00000014372, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| heterocycle catabolic process | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000009114, ENSAPLP00000014372, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| organic cyclic compound catabolic process | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000009114, ENSAPLP00000014372, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| protein metabolic process | ENSAPLP00000003943, ENSAPLP00000008397, ENSAPLP00000006744, ENSAPLP00000014548, ENSAPLP00000015503, ENSAPLP00000015706, ENSAPLP00000013972, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000009114, ENSAPLP00000015238, ENSAPLP00000014372, ENSAPLP00000011722 |
| viral infectious cycle | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| macromolecular complex disassembly | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| cellular lipid metabolic process | ENSAPLP00000011529, ENSAPLP00000005038, ENSAPLP00000009740 |
| cellular component movement | ENSAPLP00000011529, ENSAPLP00000002296, ENSAPLP00000006744, ENSAPLP00000002381, ENSAPLP00000015503 |
| cotranslational protein targeting to membrane | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| SRP-dependent cotranslational protein targeting to membrane | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| protein targeting to ER | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| protein localization to endoplasmic reticulum | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| establishment of protein localization to endoplasmic reticulum | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| ATP catabolic process | ENSAPLP00000011722, ENSAPLP00000015706 |
| muscle organ development | ENSAPLP00000002553, ENSAPLP00000002381 |
| regulation of cell cycle arrest | ENSAPLP00000005038, ENSAPLP00000015706 |
| regulation of response to DNA damage stimulus | ENSAPLP00000005038, ENSAPLP00000014372 |
| single-organism process | ENSAPLP00000009873, ENSAPLP00000003689, ENSAPLP00000006744, ENSAPLP00000002553, ENSAPLP00000015679, ENSAPLP00000013972, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000006049, ENSAPLP00000014372, ENSAPLP00000002381, ENSAPLP00000001720, ENSAPLP00000008397, ENSAPLP00000002296, ENSAPLP00000011711, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000015706, ENSAPLP00000015503, ENSAPLP00000008444, ENSAPLP00000011900, ENSAPLP00000009282, ENSAPLP00000015238 |
| cellular component organization or biogenesis | ENSAPLP00000009873, ENSAPLP00000008397, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000002296, ENSAPLP00000003689, ENSAPLP00000014548, ENSAPLP00000015503, ENSAPLP00000013972, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000015238, ENSAPLP00000006049, ENSAPLP00000014372, ENSAPLP00000002381 |
| nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| protein targeting to membrane | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| reproductive process | ENSAPLP00000011900, ENSAPLP00000009200, ENSAPLP00000011529, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| translation | ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000009114, ENSAPLP00000014372 |
| nuclear-transcribed mRNA catabolic process | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| ubiquitin-dependent protein catabolic process | ENSAPLP00000006744, ENSAPLP00000014548, ENSAPLP00000011722, ENSAPLP00000015706 |
| modification-dependent protein catabolic process | ENSAPLP00000006744, ENSAPLP00000014548, ENSAPLP00000011722, ENSAPLP00000015706 |
| modification-dependent macromolecule catabolic process | ENSAPLP00000006744, ENSAPLP00000014548, ENSAPLP00000011722, ENSAPLP00000015706 |
| establishment of protein localization to organelle | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| RNA catabolic process | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| mRNA catabolic process | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| translational initiation | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| cellular component disassembly | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| fatty acid metabolic process | ENSAPLP00000005038, ENSAPLP00000009740 |
| negative regulation of cell cycle process | ENSAPLP00000005038, ENSAPLP00000015706 |
| multi-organism process | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372, ENSAPLP00000002381, ENSAPLP00000015706 |
| proteolysis involved in cellular protein catabolic process | ENSAPLP00000006744, ENSAPLP00000014548, ENSAPLP00000011722, ENSAPLP00000015706 |
| protein folding | ENSAPLP00000003943, ENSAPLP00000014548, ENSAPLP00000015503 |
| cellular protein metabolic process | ENSAPLP00000003943, ENSAPLP00000008397, ENSAPLP00000006744, ENSAPLP00000014548, ENSAPLP00000015503, ENSAPLP00000015706, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000009114, ENSAPLP00000015238, ENSAPLP00000014372, ENSAPLP00000011722 |
| reproduction | ENSAPLP00000011900, ENSAPLP00000009200, ENSAPLP00000011529, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| proteolysis | ENSAPLP00000013972, ENSAPLP00000006744, ENSAPLP00000014548, ENSAPLP00000011722, ENSAPLP00000015706 |
| viral reproduction | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372, ENSAPLP00000015706 |
| multi-organism cellular process | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372, ENSAPLP00000015706 |
| cellular protein catabolic process | ENSAPLP00000006744, ENSAPLP00000014548, ENSAPLP00000011722, ENSAPLP00000015706 |
| ATP metabolic process | ENSAPLP00000011722, ENSAPLP00000015706 |
| cellular process involved in reproduction | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| positive regulation of cell differentiation | ENSAPLP00000011529, ENSAPLP00000009282 |
| purine nucleoside catabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| nucleoside triphosphate catabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| purine nucleoside triphosphate catabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| nucleoside catabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| ribonucleoside triphosphate catabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| purine ribonucleoside triphosphate catabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| ribonucleoside catabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| purine ribonucleoside catabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| glycosyl compound catabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| lipid metabolic process | ENSAPLP00000011529, ENSAPLP00000005038, ENSAPLP00000009740 |
| purine nucleotide catabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| purine ribonucleotide catabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| nucleotide catabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| ribonucleotide catabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| organophosphate catabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| purine-containing compound catabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| nucleoside phosphate catabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| rRNA processing | ENSAPLP00000015617, ENSAPLP00000015238 |
| proteasomal protein catabolic process | ENSAPLP00000014548, ENSAPLP00000015706 |
| rRNA metabolic process | ENSAPLP00000015617, ENSAPLP00000015238 |
| sexual reproduction | ENSAPLP00000011900, ENSAPLP00000011529 |
| monocarboxylic acid metabolic process | ENSAPLP00000005038, ENSAPLP00000009740 |
| proteasomal ubiquitin-dependent protein catabolic process | ENSAPLP00000014548, ENSAPLP00000015706 |
| muscle structure development | ENSAPLP00000002553, ENSAPLP00000002381 |
| regulation of cell death | ENSAPLP00000013972, ENSAPLP00000005038, ENSAPLP00000014372, ENSAPLP00000015706 |
| regulation of apoptotic process | ENSAPLP00000013972, ENSAPLP00000005038, ENSAPLP00000014372, ENSAPLP00000015706 |
| regulation of programmed cell death | ENSAPLP00000013972, ENSAPLP00000005038, ENSAPLP00000014372, ENSAPLP00000015706 |
| carbohydrate derivative catabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| intracellular transport | ENSAPLP00000008444, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000006744, ENSAPLP00000014372 |
| protein localization to organelle | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| cytoplasmic transport | ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| macromolecule biosynthetic process | ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000009114, ENSAPLP00000014372 |
| cellular macromolecule biosynthetic process | ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000009114, ENSAPLP00000014372 |
| positive regulation of cell death | ENSAPLP00000013972, ENSAPLP00000014372 |
| positive regulation of apoptotic process | ENSAPLP00000013972, ENSAPLP00000014372 |
| positive regulation of programmed cell death | ENSAPLP00000013972, ENSAPLP00000014372 |
| positive regulation of developmental process | ENSAPLP00000011529, ENSAPLP00000009282 |
| viral reproductive process | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| RNA biosynthetic process | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| regulation of developmental process | ENSAPLP00000011529, ENSAPLP00000001720, ENSAPLP00000009282, ENSAPLP00000005038 |
| regulation of cell differentiation | ENSAPLP00000011529, ENSAPLP00000001720, ENSAPLP00000009282 |
| multi-organism reproductive process | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| negative regulation of macromolecule metabolic process | ENSAPLP00000002553, ENSAPLP00000005038, ENSAPLP00000006744, ENSAPLP00000014372, ENSAPLP00000015706 |
| negative regulation of molecular function | ENSAPLP00000006744, ENSAPLP00000014372, ENSAPLP00000015706 |
| establishment of localization in cell | ENSAPLP00000008444, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000006744, ENSAPLP00000014372 |
| microtubule-based movement | ENSAPLP00000006744, ENSAPLP00000015503 |
| single organism reproductive process | ENSAPLP00000011900, ENSAPLP00000011529 |
| regulation of anatomical structure size | ENSAPLP00000002296, ENSAPLP00000002381 |
| negative regulation of metabolic process | ENSAPLP00000002553, ENSAPLP00000005038, ENSAPLP00000006744, ENSAPLP00000014372, ENSAPLP00000015706 |
| protein targeting | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| purine nucleoside triphosphate metabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| purine ribonucleoside triphosphate metabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| single-organism cellular process | ENSAPLP00000009873, ENSAPLP00000003689, ENSAPLP00000006744, ENSAPLP00000015679, ENSAPLP00000013972, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000006049, ENSAPLP00000014372, ENSAPLP00000002381, ENSAPLP00000001720, ENSAPLP00000008397, ENSAPLP00000002296, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000015706, ENSAPLP00000015503, ENSAPLP00000008444, ENSAPLP00000009282, ENSAPLP00000015238 |
| organic substance transport | ENSAPLP00000008444, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| ribonucleoside triphosphate metabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| purine nucleoside metabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| purine ribonucleoside metabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| organonitrogen compound catabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| localization | ENSAPLP00000008397, ENSAPLP00000011711, ENSAPLP00000006744, ENSAPLP00000015503, ENSAPLP00000008444, ENSAPLP00000015679, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000015238, ENSAPLP00000014372 |
| transport | ENSAPLP00000008397, ENSAPLP00000011711, ENSAPLP00000006744, ENSAPLP00000008444, ENSAPLP00000015679, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000015238, ENSAPLP00000014372 |
| regulation of cell cycle process | ENSAPLP00000005038, ENSAPLP00000015706 |
| negative regulation of developmental process | ENSAPLP00000001720, ENSAPLP00000005038 |
| establishment of localization | ENSAPLP00000008397, ENSAPLP00000011711, ENSAPLP00000006744, ENSAPLP00000008444, ENSAPLP00000015679, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000015238, ENSAPLP00000014372 |
| nucleoside triphosphate metabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| ribonucleoside metabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| regulation of phosphate metabolic process | ENSAPLP00000009282, ENSAPLP00000005038, ENSAPLP00000006744, ENSAPLP00000014548 |
| regulation of phosphorus metabolic process | ENSAPLP00000009282, ENSAPLP00000005038, ENSAPLP00000006744, ENSAPLP00000014548 |
| regulation of phosphorylation | ENSAPLP00000009282, ENSAPLP00000005038, ENSAPLP00000006744 |
| negative regulation of response to stimulus | ENSAPLP00000005038, ENSAPLP00000006744, ENSAPLP00000014372 |
| actin cytoskeleton organization | ENSAPLP00000014548, ENSAPLP00000002381 |
| negative regulation of protein modification process | ENSAPLP00000006744, ENSAPLP00000015706 |
| ncRNA processing | ENSAPLP00000015617, ENSAPLP00000015238 |
| regulation of cellular response to stress | ENSAPLP00000005038, ENSAPLP00000014372 |
| protein transport | ENSAPLP00000008444, ENSAPLP00000009200, ENSAPLP00000011529, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| establishment of protein localization | ENSAPLP00000008444, ENSAPLP00000009200, ENSAPLP00000011529, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| purine nucleotide metabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| nucleoside metabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| purine ribonucleotide metabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| purine-containing compound metabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| glycosyl compound metabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| cell motility | ENSAPLP00000011529, ENSAPLP00000015503 |
| localization of cell | ENSAPLP00000011529, ENSAPLP00000015503 |
| ribonucleotide metabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| ribose phosphate metabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| cell adhesion | ENSAPLP00000015617, ENSAPLP00000003689, ENSAPLP00000006049 |
| biological adhesion | ENSAPLP00000015617, ENSAPLP00000003689, ENSAPLP00000006049 |
| cellular macromolecular complex assembly | ENSAPLP00000015617, ENSAPLP00000001720, ENSAPLP00000015503 |
| homeostatic process | ENSAPLP00000015679, ENSAPLP00000011529, ENSAPLP00000001720 |
| cellular localization | ENSAPLP00000008444, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000006744, ENSAPLP00000014372 |
| apoptotic process | ENSAPLP00000014372, ENSAPLP00000002381 |
| positive regulation of cell proliferation | ENSAPLP00000009282, ENSAPLP00000005038 |
| tissue development | ENSAPLP00000015617, ENSAPLP00000002381 |
| programmed cell death | ENSAPLP00000014372, ENSAPLP00000002381 |
| chemical homeostasis | ENSAPLP00000015679, ENSAPLP00000011529 |
| negative regulation of cellular metabolic process | ENSAPLP00000002553, ENSAPLP00000006744, ENSAPLP00000014372, ENSAPLP00000015706 |
| macromolecule localization | ENSAPLP00000008444, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| cell death | ENSAPLP00000014372, ENSAPLP00000002381 |
| death | ENSAPLP00000014372, ENSAPLP00000002381 |
| ribosome biogenesis | ENSAPLP00000015617, ENSAPLP00000015238 |
| macromolecule metabolic process | ENSAPLP00000003943, ENSAPLP00000008397, ENSAPLP00000001720, ENSAPLP00000006744, ENSAPLP00000014548, ENSAPLP00000015503, ENSAPLP00000015706, ENSAPLP00000013972, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000009114, ENSAPLP00000015238, ENSAPLP00000014372, ENSAPLP00000011722 |
| actin filament-based process | ENSAPLP00000014548, ENSAPLP00000002381 |
| cellular biosynthetic process | ENSAPLP00000008397, ENSAPLP00000005038, ENSAPLP00000015617, ENSAPLP00000009200, ENSAPLP00000011529, ENSAPLP00000009114, ENSAPLP00000015238, ENSAPLP00000014372 |
| cellular macromolecule metabolic process | ENSAPLP00000003943, ENSAPLP00000008397, ENSAPLP00000001720, ENSAPLP00000006744, ENSAPLP00000014548, ENSAPLP00000015503, ENSAPLP00000015706, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000009114, ENSAPLP00000015238, ENSAPLP00000014372, ENSAPLP00000011722 |
| macromolecular complex assembly | ENSAPLP00000015617, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015503 |
| mRNA metabolic process | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372, ENSAPLP00000015706 |
| negative regulation of cellular protein metabolic process | ENSAPLP00000006744, ENSAPLP00000015706 |
| positive regulation of phosphorylation | ENSAPLP00000009282, ENSAPLP00000005038 |
| regulation of protein modification process | ENSAPLP00000005038, ENSAPLP00000006744, ENSAPLP00000015706 |
| nucleoside phosphate metabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| intracellular protein transport | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| nucleotide metabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| regulation of cellular protein metabolic process | ENSAPLP00000013116, ENSAPLP00000005038, ENSAPLP00000006744, ENSAPLP00000015706 |
| carbohydrate derivative metabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| protein localization | ENSAPLP00000008444, ENSAPLP00000009200, ENSAPLP00000011529, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| microtubule-based process | ENSAPLP00000006744, ENSAPLP00000015503 |
| ncRNA metabolic process | ENSAPLP00000015617, ENSAPLP00000015238 |
| negative regulation of catalytic activity | ENSAPLP00000006744, ENSAPLP00000015706 |
| regulation of catalytic activity | ENSAPLP00000006744, ENSAPLP00000014548, ENSAPLP00000014372, ENSAPLP00000015706 |
| organic substance biosynthetic process | ENSAPLP00000008397, ENSAPLP00000005038, ENSAPLP00000015617, ENSAPLP00000009200, ENSAPLP00000011529, ENSAPLP00000009114, ENSAPLP00000015238, ENSAPLP00000014372 |
| organophosphate metabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| positive regulation of phosphorus metabolic process | ENSAPLP00000009282, ENSAPLP00000005038 |
| regulation of MAPK cascade | ENSAPLP00000005038, ENSAPLP00000006744 |
| positive regulation of phosphate metabolic process | ENSAPLP00000009282, ENSAPLP00000005038 |
| negative regulation of protein metabolic process | ENSAPLP00000006744, ENSAPLP00000015706 |
| biosynthetic process | ENSAPLP00000008397, ENSAPLP00000005038, ENSAPLP00000015617, ENSAPLP00000009200, ENSAPLP00000011529, ENSAPLP00000009114, ENSAPLP00000015238, ENSAPLP00000014372 |
| regulation of response to stimulus | ENSAPLP00000009282, ENSAPLP00000005038, ENSAPLP00000006049, ENSAPLP00000006744, ENSAPLP00000014372 |
| regulation of biological quality | ENSAPLP00000015679, ENSAPLP00000011529, ENSAPLP00000001720, ENSAPLP00000002296, ENSAPLP00000002381 |
| RNA metabolic process | ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372, ENSAPLP00000015706 |
| nucleobase-containing compound biosynthetic process | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| nucleobase-containing small molecule metabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| cell cycle phase | ENSAPLP00000015503, ENSAPLP00000015706 |
| protein modification by small protein conjugation or removal | ENSAPLP00000006744, ENSAPLP00000015706 |
| cellular component biogenesis | ENSAPLP00000015617, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015238, ENSAPLP00000014548, ENSAPLP00000015503 |
| positive regulation of cellular process | ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000009282, ENSAPLP00000005038, ENSAPLP00000002296, ENSAPLP00000014372, ENSAPLP00000015706 |
| gene expression | ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000009114, ENSAPLP00000014372, ENSAPLP00000015706 |
| mitotic cell cycle | ENSAPLP00000015503, ENSAPLP00000015706 |
| negative regulation of signal transduction | ENSAPLP00000005038, ENSAPLP00000006744 |
| cellular component assembly | ENSAPLP00000015617, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000015503 |
| anatomical structure development | ENSAPLP00000002553, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000002381, ENSAPLP00000015503 |
| regulation of signal transduction | ENSAPLP00000009282, ENSAPLP00000005038, ENSAPLP00000006049, ENSAPLP00000006744 |
| aromatic compound biosynthetic process | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| regulation of protein phosphorylation | ENSAPLP00000005038, ENSAPLP00000006744 |
| ribonucleoprotein complex biogenesis | ENSAPLP00000015617, ENSAPLP00000015238 |
| regulation of cell cycle | ENSAPLP00000005038, ENSAPLP00000015706 |
| heterocycle biosynthetic process | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| cellular nitrogen compound biosynthetic process | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| regulation of immune system process | ENSAPLP00000001720, ENSAPLP00000005038 |
| negative regulation of cell communication | ENSAPLP00000005038, ENSAPLP00000006744 |
| negative regulation of signaling | ENSAPLP00000005038, ENSAPLP00000006744 |
| regulation of hydrolase activity | ENSAPLP00000014548, ENSAPLP00000014372 |
| cellular protein localization | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| cellular macromolecule localization | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| primary metabolic process | ENSAPLP00000006744, ENSAPLP00000009740, ENSAPLP00000013972, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000009114, ENSAPLP00000014372, ENSAPLP00000003943, ENSAPLP00000001720, ENSAPLP00000008397, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000015706, ENSAPLP00000015503, ENSAPLP00000009741, ENSAPLP00000015238, ENSAPLP00000011722 |
| small molecule metabolic process | ENSAPLP00000005038, ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000009740, ENSAPLP00000011722, ENSAPLP00000015706 |
| nucleobase-containing compound metabolic process | ENSAPLP00000008397, ENSAPLP00000001720, ENSAPLP00000015503, ENSAPLP00000015706, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000009114, ENSAPLP00000015238, ENSAPLP00000014372, ENSAPLP00000011722 |
| regulation of protein metabolic process | ENSAPLP00000013116, ENSAPLP00000005038, ENSAPLP00000006744, ENSAPLP00000015706 |
| GTP catabolic process | ENSAPLP00000009114, ENSAPLP00000015503 |
| regulation of response to stress | ENSAPLP00000005038, ENSAPLP00000014372 |
| guanosine-containing compound catabolic process | ENSAPLP00000009114, ENSAPLP00000015503 |
| single-organism metabolic process | ENSAPLP00000011529, ENSAPLP00000005038, ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000009740, ENSAPLP00000011722, ENSAPLP00000015706 |
| regulation of cellular metabolic process | ENSAPLP00000005038, ENSAPLP00000006744, ENSAPLP00000014548, ENSAPLP00000015706, ENSAPLP00000013116, ENSAPLP00000002553, ENSAPLP00000009282, ENSAPLP00000009114, ENSAPLP00000014372 |
| regulation of metabolic process | ENSAPLP00000005038, ENSAPLP00000006744, ENSAPLP00000014548, ENSAPLP00000015706, ENSAPLP00000013116, ENSAPLP00000002553, ENSAPLP00000011529, ENSAPLP00000009282, ENSAPLP00000009114, ENSAPLP00000014372 |
| nucleic acid metabolic process | ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000008397, ENSAPLP00000001720, ENSAPLP00000015238, ENSAPLP00000014372, ENSAPLP00000015706 |
| organic cyclic compound biosynthetic process | ENSAPLP00000009200, ENSAPLP00000008397, ENSAPLP00000015238, ENSAPLP00000014372 |
| cytoskeleton organization | ENSAPLP00000014548, ENSAPLP00000002381 |
| positive regulation of protein modification process | ENSAPLP00000005038, ENSAPLP00000015706 |
| locomotion | ENSAPLP00000011529, ENSAPLP00000015503 |
| organelle organization | ENSAPLP00000015617, ENSAPLP00000001720, ENSAPLP00000014548, ENSAPLP00000002381, ENSAPLP00000015503 |
| regulation of primary metabolic process | ENSAPLP00000005038, ENSAPLP00000006744, ENSAPLP00000015706, ENSAPLP00000013116, ENSAPLP00000002553, ENSAPLP00000011529, ENSAPLP00000009282, ENSAPLP00000009114, ENSAPLP00000014372 |
| positive regulation of biological process | ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000009282, ENSAPLP00000005038, ENSAPLP00000002296, ENSAPLP00000014372, ENSAPLP00000015706 |
| cellular aromatic compound metabolic process | ENSAPLP00000008397, ENSAPLP00000001720, ENSAPLP00000015503, ENSAPLP00000015706, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000009114, ENSAPLP00000015238, ENSAPLP00000014372, ENSAPLP00000011722 |
| negative regulation of cellular process | ENSAPLP00000002553, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000006744, ENSAPLP00000014372, ENSAPLP00000015706 |
| organic acid metabolic process | ENSAPLP00000005038, ENSAPLP00000009740 |
| protein complex assembly | ENSAPLP00000005038, ENSAPLP00000015503 |
| carboxylic acid metabolic process | ENSAPLP00000005038, ENSAPLP00000009740 |
| oxoacid metabolic process | ENSAPLP00000005038, ENSAPLP00000009740 |
| heterocycle metabolic process | ENSAPLP00000008397, ENSAPLP00000001720, ENSAPLP00000015503, ENSAPLP00000015706, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000009114, ENSAPLP00000015238, ENSAPLP00000014372, ENSAPLP00000011722 |
| organic substance metabolic process | ENSAPLP00000006744, ENSAPLP00000009740, ENSAPLP00000013972, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000009114, ENSAPLP00000014372, ENSAPLP00000003943, ENSAPLP00000001720, ENSAPLP00000008397, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000015706, ENSAPLP00000015503, ENSAPLP00000009741, ENSAPLP00000015238, ENSAPLP00000011722 |
| negative regulation of nucleobase-containing compound metabolic process | ENSAPLP00000002553, ENSAPLP00000014372 |
| GTP metabolic process | ENSAPLP00000009114, ENSAPLP00000015503 |
| negative regulation of nitrogen compound metabolic process | ENSAPLP00000002553, ENSAPLP00000014372 |
| protein complex biogenesis | ENSAPLP00000005038, ENSAPLP00000015503 |
| guanosine-containing compound metabolic process | ENSAPLP00000009114, ENSAPLP00000015503 |
| cellular process | ENSAPLP00000009873, ENSAPLP00000003689, ENSAPLP00000006744, ENSAPLP00000009740, ENSAPLP00000015679, ENSAPLP00000013972, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000009114, ENSAPLP00000006049, ENSAPLP00000014372, ENSAPLP00000002381, ENSAPLP00000003943, ENSAPLP00000001720, ENSAPLP00000008397, ENSAPLP00000002296, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000015503, ENSAPLP00000015706, ENSAPLP00000008444, ENSAPLP00000009282, ENSAPLP00000009741, ENSAPLP00000015238, ENSAPLP00000011722 |
| regulation of cell communication | ENSAPLP00000009282, ENSAPLP00000005038, ENSAPLP00000006049, ENSAPLP00000006744 |
| regulation of molecular function | ENSAPLP00000006744, ENSAPLP00000014548, ENSAPLP00000014372, ENSAPLP00000015706 |
| biological regulation | ENSAPLP00000006744, ENSAPLP00000013116, ENSAPLP00000002553, ENSAPLP00000015679, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000009114, ENSAPLP00000006049, ENSAPLP00000014372, ENSAPLP00000002381, ENSAPLP00000001720, ENSAPLP00000002296, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000015706, ENSAPLP00000009282 |
| organ development | ENSAPLP00000002553, ENSAPLP00000002381 |
| regulation of multicellular organismal process | ENSAPLP00000001720, ENSAPLP00000009282, ENSAPLP00000005038 |
| cellular metabolic process | ENSAPLP00000006744, ENSAPLP00000009740, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000009114, ENSAPLP00000014372, ENSAPLP00000003943, ENSAPLP00000001720, ENSAPLP00000008397, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000015706, ENSAPLP00000015503, ENSAPLP00000009741, ENSAPLP00000015238, ENSAPLP00000011722 |
| regulation of signaling | ENSAPLP00000009282, ENSAPLP00000005038, ENSAPLP00000006049, ENSAPLP00000006744 |
| cellular nitrogen compound metabolic process | ENSAPLP00000008397, ENSAPLP00000001720, ENSAPLP00000015503, ENSAPLP00000015706, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000009114, ENSAPLP00000015238, ENSAPLP00000014372, ENSAPLP00000011722 |
| positive regulation of signal transduction | ENSAPLP00000009282, ENSAPLP00000005038 |
| regulation of intracellular protein kinase cascade | ENSAPLP00000005038, ENSAPLP00000006744 |
| positive regulation of cell communication | ENSAPLP00000009282, ENSAPLP00000005038 |
| positive regulation of signaling | ENSAPLP00000009282, ENSAPLP00000005038 |
| positive regulation of cellular protein metabolic process | ENSAPLP00000005038, ENSAPLP00000015706 |
| organic cyclic compound metabolic process | ENSAPLP00000008397, ENSAPLP00000001720, ENSAPLP00000015503, ENSAPLP00000015706, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000009114, ENSAPLP00000015238, ENSAPLP00000014372, ENSAPLP00000011722 |
| organonitrogen compound metabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| system development | ENSAPLP00000002553, ENSAPLP00000002381, ENSAPLP00000015503 |
| negative regulation of gene expression | ENSAPLP00000002553, ENSAPLP00000005038 |
| cell cycle process | ENSAPLP00000015503, ENSAPLP00000015706 |
| regulation of cellular process | ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000002296, ENSAPLP00000006744, ENSAPLP00000014548, ENSAPLP00000015706, ENSAPLP00000013116, ENSAPLP00000002553, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000009282, ENSAPLP00000009114, ENSAPLP00000006049, ENSAPLP00000014372 |
| regulation of localization | ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000005038 |
| negative regulation of biological process | ENSAPLP00000002553, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000006744, ENSAPLP00000014372, ENSAPLP00000015706 |
| multicellular organismal development | ENSAPLP00000002553, ENSAPLP00000009200, ENSAPLP00000002381, ENSAPLP00000015503 |
| positive regulation of catalytic activity | ENSAPLP00000014372, ENSAPLP00000015706 |
| metabolic process | ENSAPLP00000006744, ENSAPLP00000009740, ENSAPLP00000013972, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000009114, ENSAPLP00000014372, ENSAPLP00000003943, ENSAPLP00000001720, ENSAPLP00000008397, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000015706, ENSAPLP00000015503, ENSAPLP00000009741, ENSAPLP00000015238, ENSAPLP00000011722 |
| regulation of biosynthetic process | ENSAPLP00000002553, ENSAPLP00000013116, ENSAPLP00000011529, ENSAPLP00000009282, ENSAPLP00000009114, ENSAPLP00000014372 |
| nitrogen compound metabolic process | ENSAPLP00000008397, ENSAPLP00000001720, ENSAPLP00000015503, ENSAPLP00000015706, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000009114, ENSAPLP00000015238, ENSAPLP00000014372, ENSAPLP00000011722 |
| regulation of macromolecule metabolic process | ENSAPLP00000005038, ENSAPLP00000006744, ENSAPLP00000015706, ENSAPLP00000013116, ENSAPLP00000002553, ENSAPLP00000009114, ENSAPLP00000009282, ENSAPLP00000014372 |
| positive regulation of protein metabolic process | ENSAPLP00000005038, ENSAPLP00000015706 |
| cell differentiation | ENSAPLP00000015617, ENSAPLP00000002381, ENSAPLP00000015503 |
| phosphorus metabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| phosphate-containing compound metabolic process | ENSAPLP00000009114, ENSAPLP00000015503, ENSAPLP00000011722, ENSAPLP00000015706 |
| positive regulation of response to stimulus | ENSAPLP00000009282, ENSAPLP00000005038 |
| developmental process | ENSAPLP00000002553, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000002381, ENSAPLP00000015503 |
| response to stress | ENSAPLP00000005038, ENSAPLP00000006744, ENSAPLP00000014548, ENSAPLP00000015706 |
| immune system process | ENSAPLP00000005038, ENSAPLP00000015706 |
| regulation of cell proliferation | ENSAPLP00000009282, ENSAPLP00000005038 |
| regulation of gene expression | ENSAPLP00000002553, ENSAPLP00000013116, ENSAPLP00000009282, ENSAPLP00000005038, ENSAPLP00000009114, ENSAPLP00000014372 |
| cell cycle | ENSAPLP00000015503, ENSAPLP00000015706 |
| regulation of cellular macromolecule biosynthetic process | ENSAPLP00000002553, ENSAPLP00000013116, ENSAPLP00000009282, ENSAPLP00000009114, ENSAPLP00000014372 |
| cellular developmental process | ENSAPLP00000015617, ENSAPLP00000002381, ENSAPLP00000015503 |
| regulation of transcription, DNA-dependent | ENSAPLP00000002553, ENSAPLP00000009282, ENSAPLP00000009114, ENSAPLP00000014372 |
| regulation of biological process | ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000002296, ENSAPLP00000006744, ENSAPLP00000014548, ENSAPLP00000015706, ENSAPLP00000013116, ENSAPLP00000002553, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000009282, ENSAPLP00000009114, ENSAPLP00000006049, ENSAPLP00000014372 |
| positive regulation of molecular function | ENSAPLP00000014372, ENSAPLP00000015706 |
| regulation of macromolecule biosynthetic process | ENSAPLP00000002553, ENSAPLP00000013116, ENSAPLP00000009282, ENSAPLP00000009114, ENSAPLP00000014372 |
| regulation of RNA biosynthetic process | ENSAPLP00000002553, ENSAPLP00000009282, ENSAPLP00000009114, ENSAPLP00000014372 |
| single-organism developmental process | ENSAPLP00000002553, ENSAPLP00000009200, ENSAPLP00000002381 |
| regulation of cellular biosynthetic process | ENSAPLP00000002553, ENSAPLP00000013116, ENSAPLP00000009282, ENSAPLP00000009114, ENSAPLP00000014372 |
| single-multicellular organism process | ENSAPLP00000002553, ENSAPLP00000009200, ENSAPLP00000002381, ENSAPLP00000015503 |
| positive regulation of cellular metabolic process | ENSAPLP00000009282, ENSAPLP00000005038, ENSAPLP00000015706 |
| positive regulation of macromolecule metabolic process | ENSAPLP00000009282, ENSAPLP00000005038, ENSAPLP00000015706 |
| RNA processing | ENSAPLP00000015617, ENSAPLP00000015238 |
| regulation of RNA metabolic process | ENSAPLP00000002553, ENSAPLP00000009282, ENSAPLP00000009114, ENSAPLP00000014372 |
| intracellular signal transduction | ENSAPLP00000001720, ENSAPLP00000015706 |
| multicellular organismal process | ENSAPLP00000002553, ENSAPLP00000009200, ENSAPLP00000002381, ENSAPLP00000015503 |
| regulation of nitrogen compound metabolic process | ENSAPLP00000002553, ENSAPLP00000009282, ENSAPLP00000009114, ENSAPLP00000014372, ENSAPLP00000015706 |
| positive regulation of metabolic process | ENSAPLP00000009282, ENSAPLP00000005038, ENSAPLP00000015706 |
| regulation of nucleobase-containing compound metabolic process | ENSAPLP00000002553, ENSAPLP00000009282, ENSAPLP00000009114, ENSAPLP00000014372 |
| cellular protein modification process | ENSAPLP00000006744, ENSAPLP00000015706 |
| protein modification process | ENSAPLP00000006744, ENSAPLP00000015706 |
| macromolecule modification | ENSAPLP00000006744, ENSAPLP00000015706 |
| signal transduction | ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015706 |
| signaling | ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015706 |
| single organism signaling | ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015706 |
| cell communication | ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015706 |
| response to stimulus | ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000006744, ENSAPLP00000014548, ENSAPLP00000002381, ENSAPLP00000015706 |
| cellular response to stimulus | ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000015706 |
|